Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin-1 receptor antagonist

A C Lennard1

  • 1Yamanouchi Research Institute U.K., Littlemore Hospital, Oxford, U.K.

Critical Reviews in Immunology
|January 1, 1995
PubMed
Summary

Interleukin-1 receptor antagonist (IL-1ra) exists in two forms: secreted (sIL-1ra) and intracellular (icIL-1ra). Research explores their genetics, regulation, and roles in inflammatory diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

3-(13-Hydroxytridecyl)-1-[13-(3-pyridyl)tridecyl]pyridinium chloride (YM-53792), a novel inhibitor of NF-AT activation.

Biochemical pharmacology·1997
Same author

Comparison of two promoters controlling expression of secreted or intracellular IL-1 receptor antagonist.

Journal of immunology (Baltimore, Md. : 1950)·1994
Same author

The bidirectional promoter of the divergently transcribed mouse Surf-1 and Surf-2 genes.

Molecular and cellular biology·1991
Same author

Stereospecific relationships between elements in an SV40/adenovirus-2 heterologous promoter.

Nucleic acids research·1989
Same author

The bidirectional upstream element of the adenovirus-2 major late promoter binds a single monomeric molecule of the upstream factor.

The EMBO journal·1987
Same author

The arrangement of H5 molecules in extended and condensed chicken erythrocyte chromatin.

The EMBO journal·1985

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Interleukin-1 receptor antagonist (IL-1ra) is a unique naturally occurring cytokine receptor antagonist.
  • Intensive research has focused on IL-1ra genetics and therapeutic potential since its cDNA cloning.
  • The discovery of two IL-1ra forms, secreted (sIL-1ra) and intracellular (icIL-1ra), has added complexity.

Purpose of the Study:

  • To review the genetics of the IL-1RN gene.
  • To explore mechanisms of IL-1ra gene activation for both sIL-1ra and icIL-1ra production.
  • To discuss the biological roles of IL-1ra isoforms in health and disease.

Main Methods:

  • Review of existing literature on IL-1ra genetics and regulation.
  • Analysis of gene activation mechanisms.
  • Discussion of evidence from animal models and potential therapeutic applications.

Main Results:

  • IL-1ra is encoded by a single gene (IL-1RN) with two promoters regulating expression of sIL-1ra and icIL-1ra via alternative first exon usage.
  • Animal models show efficacy of exogenous IL-1ra in inflammatory diseases.
  • The distinct biological roles of sIL-1ra and icIL-1ra are still under investigation.

Conclusions:

  • IL-1ra, in its two forms, is crucial in the pathogenesis of acute and chronic inflammatory diseases.
  • Further investigation into the therapeutic potential of recombinant IL-1ra in human diseases is ongoing.
  • Understanding IL-1ra gene regulation is key to its immunomodulatory functions.

Related Experiment Videos